| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/11/16 | 8-K | Current report filing |
|
6 | |
| 04/29/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/27/16 | 8-K | Current report filing |
|
5 | |
| 04/15/16 | 8-K | Current report filing |
|
57 | |
| 04/13/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
50 |
| 03/29/16 | 8-K | Current report filing |
|
43 | |
| 03/22/16 | 8-K | Current report filing |
|
6 | |
| 03/08/16 | 8-K | Current report filing |
|
5 | |
| 02/25/16 | DEF 14A | Definitive proxy statements |
|
31 | |
| 02/19/16 | 8-K | Current report filing |
|
5 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.